
Pharma Pulse 1/3/25: Navigating Fertility Misinformation on Social Media, Nearly 75% of Adolescents Experience Depression/Anxiety & more
The latest news for pharma industry insiders.
In this part of his Pharmaceutical Executive video interview, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (
Female adolescents were at an increased risk of experiencing depression and anxiety symptoms compared with males.
The rural region is changing fast as electricians from around the country plug the tech industry’s new, giant data centers into its ample power supply.
McKesson Corporation reported that on December 30, 2024 it has closed the transaction announced in September 2024 to sell its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, a Canadian private equity firm. This transaction enables the Company to focus capital deployment and prioritize investments expanding its strategic oncology and biopharma growth platforms.
🌟 Exciting End-of-Year Highlights from Systech International!
As we wrap up 2024, we’re reflecting on key developments like the phased approach to DSCSA compliance and its impact on the pharmaceutical supply chain. Our Director of Product Management, Joseph Lipari, shared valuable insights in a two-part interview with
This year also saw us offering tips to streamline traceability and exception management, ensuring smoother transitions for industry stakeholders.
Read the full article and stay tuned for more insights into trends and innovations shaping 2025! 🚀
#DSCSA #pharma #traceability
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

